Ophthalmology Doctors in Palm Desert, CA Accepting Medicare

16 Ophthalmology doctors found. Showing 1 - 16

Lori L. Kirshner, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 44435 Town Center Way, Suite B, Palm Desert, CA 92260 Phone: 760-322-6002    Fax: 760-341-2947

Harry Marshak, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 74075 El Paseo, D2, Palm Desert, CA 92260 Phone: 760-341-2551    Fax: 760-341-2522

Clement K. Chan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 36949 Cook St Ste 101, Palm Desert, CA 92211 Phone: 760-340-2394    Fax: 760-340-2369

Alireza Ghaffarieh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave Ste A, Palm Desert, CA 92260 Phone: 626-269-5371    Fax: 626-577-2100

Steven G Lin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 36949 Cook St Ste 101, Palm Desert, CA 92211 Phone: 760-340-2394    Fax: 760-340-2369

Dr. Peter S. Spiegel, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 44435 Town Center Way, Suite B, Palm Desert, CA 92260 Phone: 760-322-6002    Fax: 760-341-2947

Dr. James Kevin Belville, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave Ste A, Palm Desert, CA 92260 Phone: 760-469-5195

Jennifer I Hui, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 41990 Cook St, Building F #1007, Palm Desert, CA 92211 Phone: 760-610-2677    Fax: 760-610-6101

Dr. Erik Jan Williams, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 36921 Cook St, Suite #103, Palm Desert, CA 92211 Phone: 760-568-3111    Fax: 760-836-1151

Dr. Rebecca Lynne Chait, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave Ste A, Palm Desert, CA 92260 Phone: 800-898-2020    Fax: 844-897-3788

Michael A Samuel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave Ste A, Palm Desert, CA 92260 Phone: 760-779-0800    Fax: 760-779-0801

Steven Fish, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave Ste A, Palm Desert, CA 92260 Phone: 760-779-0800    Fax: 848-973-7888

Dung Q Le, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 36921 Cook St, Suite 103, Palm Desert, CA 92211 Phone: 760-836-3937    Fax: 760-836-1151

Jerome Allen Chatow, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 35935 Royal Sage Ct, Palm Desert, CA 92211 Phone: 760-772-1147    Fax: 206-203-1274

Dr. Alexander M Chop, PH.D. M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave Ste A, Palm Desert, CA 92260 Phone: 760-779-0800    Fax: 760-779-0801

Joel M Solano, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 44139 Monterey Ave, A, Palm Desert, CA 92260 Phone: 760-779-0800    Fax: 760-779-0801

News Archive

Research shows choroid plexus can act as a conduit for prenatal inflammation

Floating in fluid deep in the brain are small, little understood fronds of tissue. Two new studies reveal that these miniature organs are a hotbed of immune system activity.

New global health initiative focuses on improving public health

The American College of Sports Medicine has announced a new global health initiative called ActivEarth. With an innovative, global-scale, science-based and science-informed approach, ActivEarth will focus on improving public health, the environment and the economy through greater levels of physical activity, particularly active transportation.

Anxiety can give older men a heart attack

Researchers in the United States say men who suffer from anxiety are more likely than the others to have a heart attack.

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.

Read more Medical News

› Verified 6 days ago